论文部分内容阅读
常用的幽门螺杆菌(Hp)根除一线治疗方案为PPI加克拉霉素加阿莫西林或甲硝唑治疗。但随着Hp耐药菌株的比例越来越高,耐药往往成为治疗失败的主要原因。有报道[1]认为国际上多采用的标准三联治疗方案Hp根除率已降至67.2%。铋剂四联治疗是目前难治性Hp感染的最常用补救方案。有研?
The commonly used first-line treatment for Helicobacter pylori (Hp) is PPI plus clarithromycin plus amoxicillin or metronidazole. However, as the proportion of Hp-resistant strains increases, resistance often becomes the primary cause of treatment failure. It has been reported [1] that the standard triple therapy Hp eradication rate has dropped to 67.2%. Bismuth quadruple therapy is currently the most common remedy for refractory Hp infection. Research?